Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Balchem (BCPC)

Balchem Q3 2025 net sales rise 11.5% to $267.6 million; GAAP EPS $1.24

Positive Impact 3 of 5 earnings Written later

Balchem Corporation reported third quarter 2025 results for the period ended September 30, 2025, with net sales up 11.5% to $267.6 million and GAAP net earnings up 19.1% to $40.3 million. Both sales and earnings grew in all three reporting segments, and the filing gives no revised full-year guidance.

Key points

  • Net sales were $267.6 million, up $27.6 million or 11.5% from the prior year quarter.
  • GAAP diluted EPS was $1.24 versus $1.03; adjusted EPS was $1.35 versus $1.13.
  • Adjusted EBITDA was $71.4 million, up 11.0%, and free cash flow was $50.7 million.
  • The company made $36.0 million of net revolving loan repayments and repurchased $15.4 million of common stock in the quarter.

The filing

CompanyBalchem (BCPC)
Form8-K, current report
Filed with the SECOct 21, 2025, 7:17 AM ET
Accession number0000009326-25-000019

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 21, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.